Product Reports Resources Pricing Login Book a demo

Integra Therapeutics

Biotech & Life Sciences · Barcelona, Spain · Founded 2020

Integra Therapeutics is a biotech company developing next-generation gene writing tools to cure genetic diseases MoreLess

Integra-TX is a technology startup that operates in the digital communications sector. The company's primary service involves the provision of technical storage and access solutions. These solutions are designed to facilitate the use of specific services requested by subscribers or users, and to enable the transmission of communication across electronic communication networks.

Integra-TX's services are essential for businesses that rely on digital communication and data storage. The company's solutions are designed to store user preferences, which are not explicitly requested by the subscriber or user. This feature is particularly useful for businesses that want to enhance their customer service by understanding and anticipating their customers' needs and preferences.

Moreover, Integra-TX also offers services that are used exclusively for statistical purposes. This means that the company provides tools that allow businesses to collect and analyze data about their operations and customers. This data can be used to make informed decisions and improve business performance.

One of the unique features of Integra-TX's services is the emphasis on user privacy. The company ensures that the information stored or retrieved cannot be used to identify the user without additional records from a third party or voluntary compliance from the internet service provider.

Finally, Integra-TX also offers services that are used to create user profiles for advertising purposes and to track users across different websites for similar marketing purposes. This means that the company provides tools that allow businesses to target their marketing efforts more effectively.

In terms of its business model, Integra-TX makes money by charging its clients for the use of its technical storage and access solutions.

Keywords: Technology Startup, Digital Communications, Technical Storage, User Preferences, Statistical Analysis, User Privacy, User Profiling, Advertising, Marketing, Business Model.

Company overview

Integra Therapeutics company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2020
Headquarters
Barcelona, Spain
Employees
23
Open positions
None listed
Dealroom signal
75.8
client focusb2bsub industryPharmaceuticalsub industryBioTechnologybusiness modelManufacturingindustryHealthsectorBiotechnologysectorGene TherapysectorSpinoutsectorEICsectorBiotech and PharmasectorEIC FundsectorEIT HealthsectorWoman FoundersectorEIT Ecosystem

Valuation & funding

Integra Therapeutics funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SEEDEquity / VC Sep 2025 $12M $47M AdBio partners · Invivo Partners · CDTI Innvierte · Takeda Ventures
SUPPORT PROGRAMOther financing Jan 2025 $0 EIT Health
GRANTOther financing Mar 2024 $2.5M European Innovation Council
EARLY VCEquity / VC Mar 2024 $0 EIC Fund
SUPPORT PROGRAMOther financing Jan 2023 $0 EIT Health
SEEDEquity / VC Mar 2022 Columbus Venture Partners
SEEDEquity / VC Dec 2021 AdBio partners · Takeda · Invivo Partners
SUPPORT PROGRAMOther financing Jan 2021 EIT Health
SPINOUTOther financing Jan 2020 Pompeu Fabra University
Showing 9 recorded eventsUnlock the complete deal history →

Financials

Revenue, earnings and profit over time

Reported history and available estimates. Estimated years are marked “E”; sparse fields are left blank rather than inferred.

YearRevenueGrowthProfitMargin
2026 $11K 0% −$680K -6404.8%
2025 $11K 0% −$680K -6404.8%
2024 $11K 0% −$680K -6404.8%
2023 $11K
2022
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

Integra Therapeutics website traffic

Latest recorded traffic for Integra Therapeutics is 1.1K monthly website visits, down 57.7% over the last three months. Integra Therapeutics's team declined 4.2% over the past year.

Latest monthly visits1.1K 3-month web change-57.7% 1-year team growth-4.2%
Monthly website visits41 observations · Oct 2022–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Integra Therapeutics compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

Integra Therapeutics's talent

Book a demo to see the people
Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

10 investors on Integra Therapeutics's cap table

Sourced from Dealroom's funding and investor records.

Seed 7 investors entered at this stage
AdBio partners
Takeda
Invivo Partners
Columbus Venture Partners
European Innovation Council
CDTI Innvierte
Takeda Ventures
Series A 1 investor entered at this stage
EIC Fund
Other known 2 additional known investors
EIT Health
Pompeu Fabra University

Global footprint

Where Integra Therapeutics has talent and traffic

Workforce by country
4 countries with
team presence
🇪🇸 Spain79.2%
🇳🇱 Netherlands8.3%
🇺🇸 United States8.3%
🇨🇴 Colombia4.2%
4 countries shown

In the news

Latest news about Integra Therapeutics

Recent press, funding announcements, and product moves mentioning Integra Therapeutics — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Integra Therapeutics

An AI-synthesized read of the highest-engagement posts about Integra Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Integra Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.